Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 1,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 23,409 | 25,708 | 57,601 | 29,050 | 19,145 |
| Operating Income | -22,409 | -25,708 | -57,601 | -29,050 | -19,145 |
| Other Income | 1,626 | 2,538 | 897 | 76 | 132 |
| Pre-tax Income | -20,783 | -23,170 | -56,704 | -28,974 | -19,013 |
| Income Tax | -798 | -2,330 | -2,479 | -1,508 | -10,872 |
| Net Income Continuous | -19,985 | -20,840 | -54,225 | -27,466 | -8,141 |
| Minority Interests | N/A | N/A | N/A | N/A | 9 |
| Net Income | $-19,985 | $-20,840 | $-54,225 | $-27,466 | $-8,150 |
| EPS Basic Total Ops | -2.40 | -2.58 | -10.47 | -7.45 | -7.95 |
| EPS Basic Continuous Ops | -2.40 | -2.58 | -10.47 | -7.45 | -7.91 |
| EPS Diluted Total Ops | -2.40 | -2.58 | -10.47 | -7.45 | -7.95 |
| EPS Diluted Continuous Ops | -2.40 | -2.58 | -10.47 | -7.45 | -7.91 |
| EPS Diluted Before Non-Recurring Items | -2.40 | -2.58 | -4.07 | -7.50 | -20.39 |
| EBITDA(a) | $-22,690 | $-26,479 | $-56,744 | $-26,481 | $-18,775 |